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Protective effect of anti‑SUAM
antibodies on Streptococcus uberis mastitis
Raúl A. Almeida1*, Oudessa Kerro‑Dego1, María E. Prado1, Susan I. Headrick1, Mark J. Lewis2, Lydia J. Siebert1,
Gina M. Pighetti1 and Stephen P. Oliver1

Abstract
In the present study, the effect of anti-recombinant Streptococcus uberis adhesion molecule (SUAM) antibodies against
S. uberis intramammary infections (IMI) was evaluated using a passive protection model. Mammary quarters of healthy
cows were infused with S. uberis UT888 opsonized with affinity purified anti-rSUAM antibodies or hyperimmune sera.
Non-opsonized S. uberis UT888 were used as a control. Mammary quarters infused with opsonized S. uberis showed
mild-to undetectable clinical symptoms of mastitis, lower milk bacterial counts, and less infected mammary quarters
as compared to mammary quarters infused with non-opsonized S. uberis. These findings suggest that anti-rSUAM
antibodies interfered with infection of mammary gland by S. uberis which might be through preventing adherence to
and internalization into mammary gland cells, thus facilitating clearance of S. uberis, reducing colonization, and caus‑
ing less IMI.
Introduction
Environmental streptococci, particularly Streptococcus
uberis, account for a significant proportion of mastitis in lactating and nonlactating cows [1–3], and heifers
[4]. Current prevention and control programs originally
designed for the control of contagious mastitis pathogens such as Streptococcus agalactiae are only marginally effective against S. uberis. Susceptibility to S. uberis
mastitis varies during the different stages of the lactation
cycle, showing the highest prevalence during the early
nonlactating and periparturient periods [5, 6].
Research conducted in our lab lead to the discovery of
a novel S. uberis virulence factor identified as S. uberis
adhesion molecule (SUAM) [7]. SUAM is a fibrillar surface protein associated with the S. uberis cell wall by a
hydrophobic region, and has affinity for lactoferrin (LF).
Further in vitro studies showed that SUAM plays a central
role during the early events of S. uberis IMI via adherence
to and internalization into bovine mammary epithelial
cells (BMEC). Mechanisms underlying the pathogenic
involvement of SUAM rely partially on its affinity for LF,
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which together with a putative receptor on the surface of
BMEC creates a molecular bridge which facilitates adherence to and internalization of S. uberis into BMEC [7–9].
We also discovered that SUAM has a LF-independent
domain that also mediates adherence and internalization,
and that anti-SUAM antibodies blocked both pathogenic
mechanisms [9]. Further studies using a SUAM deletion
mutant showed that adherence and internalization of the
SUAM mutant strain into BMEC was markedly reduced
as compared with the parent S. uberis strain [10].
In an attempt to enhance mammary immunity during the late nonlactating and periparturient periods,
we conducted a vaccination study using recombinant
SUAM (rSUAM) as antigen. Results showed that significant increases in anti-rSUAM antibodies in serum and
mammary secretions can be achieved during these high
mastitis prevalence periods [11]. Furthermore, vaccination-induced anti-rSUAM antibodies inhibited in vitro
adherence to and internalization of S. uberis into BMEC
[11]. The purpose of the present study was to extend our
observations by using an in vivo approach to evaluate the
effect of anti-rSUAM antibodies on the pathogenesis of S.
uberis IMI.

© 2015 Almeida et al. This article is distributed under the terms of the Creative Commons Attribution 4.0 International License
(http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium,
provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license,
and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/
publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
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Materials and methods
Antibody production

Recombinant SUAM was purified as described [11]. Concentrated rSUAM was sent to Quality Bioresources, Inc.
(Seguin, TX, USA) for production of antibodies. AntirSUAM antibodies were affinity purified from sera of
rSUAM-immunized steers using rSUAM conjugated to
Ultra Link Biosupport (Thermo Scientific, Rockford, IL,
USA) and eluted with 0.1 M citrate buffer. Final antibody
concentration as determined by ELISA was 21.0 mg/mL.
Bacterial strain, culture conditions and preparation
of challenge suspension

Streptococcus uberis UT888, a strain originally isolated
from a cow with chronic mastitis, was used in this study
[1]. Frozen stocks of S. uberis UT888 were thawed in a
37 °C water bath, streaked onto blood agar plates (BAP),
and incubated for 16 h at 37 °C in a CO2: air balanced
incubator. A single colony from the BAP culture was
used to inoculate 50 mL of Todd Hewitt broth (THB,
Becton–Dickinson, Franklin Lakes, NJ, USA) and incubated for 16 h at 37 °C in an orbital rocking incubator
at 150 rpm. The resulting suspension was then diluted
in PBS (pH 7.4) to a concentration of 4.0 log10 colony
forming units/mL (CFU/mL), mixed with anti-rSUAM
antibodies at a final concentration of 15.0 mg/mL and
further incubated for 1 h at 37 °C. The challenge suspension used for positive control mammary quarters was
prepared in parallel but omitting the addition of antirSUAM antibodies.
Challenge protocol

Twenty mastitis-free (negative bacteriological culture
and milk SCC <250 000 cells/mL at quarter level) Holstein cows in their 2nd and 3rd lactations and in their
first 60 days of the lactation were used. Cows were allocated randomly to the experimental (n = 10) or positive
control (n = 10) groups. One mammary quarter of each
cow in the experimental group was infused with S. uberis
UT888 opsonized with affinity-purified anti-rSUAM
antibodies (opsonized S. uberis). One uninfected mammary quarter of cows in the control group was infused

with non-opsonized S. uberis UT888. Non-infused quarters were used as negative controls. The experimental
IMI protocol was approved by The University of Tennessee Institutional Animal Care and Use Committee.
Clinical assessment of animals following challenge

Challenged cows were monitored twice daily during
the 1st week (CH0 through CH + 7), and once daily at
CH + 10 and CH + 14. During these inspections, rectal temperature, clinical assessment of milk and mammary glands, as well as local signs of inflammation were
monitored and recorded. Milk and mammary scores
were evaluated using a scoring system described in
Table 1.
Mammary quarters were considered infected and classified as IMI as described [12]. Subclinical mastitis was
defined as quarters without clinical signs having positive isolation of S. uberis (≥500 colony forming units per
mL (CFU/mL)) and/or corresponding increase of SCC
(>2.5 × 105). Clinical mastitis was defined as quarters
having scores of >2 for milk and mammary appearance.
Milk sample evaluation

Samples of foremilk were collected aseptically from each
mammary quarter 7 days before challenge (CH − 7),
immediately before challenge, twice daily at milking
from CH0 through CH + 7 and once daily at CH + 10
and CH + 14. Microbiological evaluation of milk samples
was done following procedures recommended by NMC.
Identification of S. uberis strains used was as described
[4, 13]. Milk somatic cell counts (SCC) were analyzed at
the Dairy Herd Improvement Association Laboratory,
Knoxville, TN, USA.
Statistical analysis

Data on mammary scores, SCC and bacterial counts
were analyzed using SAS software (Cary, NC, USA). A
mixed model repeated measures (autoregressive variance
structure) with cow as the subject was used to compare
strains, time, and their interaction.
Least squares means were separated using Fisher’s protected LSD at the 5% significance level. Variables were

Table 1 Mammary gland and milk evaluation and scoring.
Score

Milk appearance

Mammary score
Palpation

Demeanor
Temp.

Color

0

Normal

Pliable, light

Normal

Normal

None

1

Flakes

Slight, firmness, swelling

Normal

Normal

None

2

Clots

Firm, moderate swelling

Warm

Red

None

3

Stringy, watery, bloody

Hard, severe swelling

Hot

Red

Uncomfortable, irritable, kicks

Almeida et al. Vet Res (2015) 46:133

Page 3 of 6

examined for normality (Shapiro–Wilk >0.90) and equal
variance, which showed bacterial counts needed log
transformation.

Results
Mammary scores

Inflammatory changes in milk and mammary quarters infused with opsonized S. uberis were significantly
lower than in cows infused with non-opsonized S. uberis
(positive control group) (Figure 1). Mammary quarters
infused with non-opsonized S. uberis began to show
clinical signs of mastitis 36 h post-challenge, reaching the
highest milk appearance and mammary score/demeanor at 3 (CH + 3) and 6 (CH + 6) days post-challenge,
respectively. In contrast, mammary quarters infused with
opsonized S. uberis had the highest milk appearance and
mammary score 1 week post-challenge. During days 2–9
post-challenge, mammary scores of quarters infused with
opsonized S. uberis were significantly lower than changes
observed in mammary quarters infused with nonopsonized S. uberis (P ≤ 0.05). No scores were detected
in milk or mammary gland parenchyma of non-infused
quarters (negative controls).

Microbiological findings

Milk from mammary quarters infused with opsonized S.
uberis had significantly lower bacterial counts than quarters infused with non-opsonized S. uberis (Figure 2). In
mammary quarters challenged with non-opsonized S.
uberis, the maximum numbers of bacteria in milk were
detected on days 3 and 6 post-challenge and were about
2.5 log10 higher than values used to challenge mammary
quarters. In contrast, during the same period (CH + 2–
CH + 6), numbers of bacteria in milk from mammary
quarters infused with opsonized S. uberis were significantly lower than the corresponding number for the control group (P ≤ 0.05). No bacteria were isolated from
milk of the negative controls quarters.
Somatic cell counts

Somatic cells counts in milk of challenged quarters of
the opsonized and control group, increased markedly
after challenge and continued increase throughout the
observation period (Figure 3). Somatic cell counts of the
opsonized group were lower than these of the control
groups reaching statistically significant level at CH + 6
and CH + 7 (P ≤ 0.05).

Mammary Scores (milk + parenchyma)

3.5

Cntrl
Op

3

2.5

2

1.5

1

0.5

0

Days relative to challenge (CH)
Figure 1 Milk and mammary parenchyma scores of challenged quarters. Twenty uninfected bovine mammary quarters were challenged
with S. uberis UT888 opsonized with anti- rSUAM antibodies ( ) or the untreated S. uberis UT888 ( ) and milk and mammary scores were obtained.
Data are the sum of milk and mammary scores and each data point represents the mean of two daily observations for all challenged quarters in
each group. Error bars are the standard error of the mean (SEM). Values included in the dotted line box were statistically significant (P ≤ 0.05).
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Figure 2 Log10 colony forming units/mL (CFU/mL) of S. uberis UT888. Twenty uninfected bovine mammary quarters were challenged with
S. uberis UT888 opsonized with anti-rSUAM antibodies ( ) or untreated S. uberis UT888 ( ) and CFU/mL in milk of challenged quarters were
obtained. Data are presented as log10 CFU/mL and are the mean of daily observations for the 1st week and at 10 and 14 days post-challenge for
each treatment group. Error bars are the standard error of the mean (SEM). The dotted line box includes time points where differences between
groups were statistically significant (P ≤ 0.05).

Clinical signs

Sixty percent of mammary quarters infused with nonopsonized S. uberis developed clinical mastitis and
such percentage was significantly higher as compared
to mammary quarters infused with opsonized S. uberis
(Figure 4). Intramammary infections (IMI) were detected
in all quarters infused with the non-opsonized strain and
in 10% of the quarters infused with S. uberis treated with
anti-rSUAM antibodies. In addition, by the day 14 after
challenge, IMI was detected in 50% of the quarters. In
contrast, 20% of the quarters of the opsonized group had
IMI. Only mild clinical signs of mastitis were observed in
mammary quarters infused with opsonized S. uberis and
while 50% of the control cows required antibiotic therapy, no treatment was needed for cows in the opsonized
group (data not shown).

Discussion
In a previous communication, we reported a novel virulence factor from S. uberis identified as S. uberis adhesion molecule (SUAM) [7]. Further research showed that
this molecule had a central role on adherence and internalization of S. uberis into BMEC and that anti SUAM

antibodies from immunized cows were able to reduce
adherence to and internalization of S. uberis into BMEC
[11]. Even though these results were very promising, the
lack of data generated from in vivo approaches was the
piece missing in our research. To solve this void, we conducted an in vivo passive protection assay to specifically
answer the question about the protective effect of antiSUAM antibodies.
Passive immunity is the transfer of antibodies from
one individual to another and occurs naturally when
maternal antibodies are transferred to the fetus through
the placenta, or when antibodies specific for a pathogen
or toxin are passively transferred to achieve immediate protection against a specific pathogen [14]. Passive
protection is the status obtained by passive immunity
and assays directed to test the efficacy of specific antibodies to neutralize pathogens or toxins are known as
in vivo passive protection assay. Typically, in vivo passive protection assay consists of treatment of susceptible
individuals with specific antibodies before experimental exposure to the target pathogen. Protective effect
of the test antibodies is determined by measuring the
reduction of symptoms or progression of the disease as
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Figure 3 Somatic cell counts (SCC) in milk from challenged quarters. Twenty uninfected bovine mammary quarters were challenged with
S. uberis UT888 opsonized with anti-rSUAM antibodies ( ) or untreated S. uberis UT888 ( ) and SCC/mL in milk of challenged quarters were
obtained. Data are daily values obtained during the first 7 days following challenge (CH) and error bars are the standard error of the mean (SEM).
The dotted line box includes differences statistically significant (P ≤ 0.05).
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Figure 4 Intramammary infections (IMI) detected in mammary quarters infused with non-opsonized S. uberis UT888 or opsonized
with anti-rSUAM antibodies. Infused mammary quarters were infused with non-opsonized S. uberis UT888 (A) or opsonized with anti-rSUAM
antibodies (B) and monitored daily for 2 weeks. Mammary quarters were classified as clinical ( ) subclinical ( ) or negative ( ) based on milk appear‑
ance and mammary scores, and microbiological data. Bars indicate the number of IMI detected in each group.

compared to non-treated controls [15–17]. In this study,
we used a variation of such a method. In our approach, S.
uberis was opsonized with anti-rSUAM antibodies prior
to infusion into healthy mammary glands of dairy cows

and similarly as a control the same non-treated strain
infused into healthy mammary glands. Results showed
that mammary quarters infused with S. uberis opsonized
with anti-rSUAM antibodies had less clinical mastitis,
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with mild symptoms, and lower bacterial counts in milk
as compared to control quarters. Somatic cells counts
and bacterial counts in CFU/mL were lower in mammary glands infused with S. uberis opsonized with antirSUAM antibodies from CH + 2 to CH + 5. In spite of
these differences, by CH + 10 CFU/mL were higher in
milk of quarters infused with opsonized S. uberis that in
the control group. Such differences could be due to the
fact that in absence of active production of anti-SUAM
antibodies, a fraction of S. uberis not affected by the
blocking effect of these antibodies or innate defenses
of the mammary gland follow the pathogenic pathways
of S. uberis IMI, resulting in augmented CFU/mL in
the milk of these cows. It is important to note that the
concentration of anti-rSUAM antibodies used (15.0 mg/
mL) was about 5 times more concentrated than normal
IgG values (~3 mg/mL) during the peripartum period in
dairy cows, as reported [18]. This suggests that optimization of local antibody responses through strategic vaccination schedules and routes of administration need to
be achieved in order to confer effective protection during the peripartum period.
Findings reported in this communication indicate that
anti-rSUAM antibodies have a protective effect against
S. uberis IMI, possibly either by blocking adherence and
internalization of S. uberis into host cells [11], and/or
likely by mediating the S. uberis phagocytosis by neutrophils and macrophages in the mammary glands. These
findings confirm our previous in vitro observations about
the protective role of anti-rSUAM antibodies [11] and
establish the value of our in vitro experimental model
based on cocultures of BMEC with S. uberis as an initial
step in identification of S. uberis virulence factors.
In conclusion, results from this investigation demonstrated that anti-rSUAM antibodies partially protected
mammary glands from S. uberis infection following
experimental challenge most likely by preventing adhesion and invasion of bacteria into host cells and/or
through opsono-phagocytic removal of bacteria by
phagocytic cells.
Competing interests
The authors declare that they have no competing interests.
Author details
1
Department of Animal Science, The University of Tennessee, Knoxville, TN
37996‑4574, USA. 2 Little River Animal and Environmental Unit, East Tennessee
AgResearch and Education Center, Walland, TN 37886, USA.
Authors’ contributions
RAA, OKD, and SPO participated in design of the study, carried out the experi‑
ments and statistical analysis, and contributed to drafting of the manuscript.
MEP was responsible for elaboration of rSUAM, and SIH conducted the
microbiology analysis. MJL, LJS, GMP, OKD as well as RAA and SIH participated
in conduction of animal experiments of this study. All authors read and
approved the final manuscript.

Page 6 of 6

Acknowledgements
This project was supported by the Agriculture and Food Research Initiative
Competitive Grant no. 2011-67015-30168 from the USDA National Institute of
Food and Agriculture, and the AgResearch Innovation Grant Program from The
University of Tennessee Institute of Agriculture.
Received: 14 July 2015 Accepted: 15 October 2015

References
1. Oliver SP (1988) Frequency of isolation of environmental mastitis-causing
pathogens and incidence of new intramammary infection during the
nonlactating period. Am J Vet Res 49:1789–1793
2. Hogan JS, Smith KL, Hoblet KH, Schoenberger PS, Todhunter DA, Hueston
WD, Pritchard DE, Bowman GL, Heider LE, Brockett BL (1989) Field survey of
clinical mastitis in low somatic cell count herds. J Dairy Sci 72:1547–1556
3. Leigh JA (1999) Streptococcus uberis: a permanent barrier to the control of
bovine mastitis? Vet J 157:225–238
4. Oliver SP, Gillespie BE, Jayarao BM (1998) Detection of new and persistent
Streptococcus uberis and Streptococcus dysgalactiae intramammary infec‑
tions by polymerase chain reaction-based DNA fingerprinting. FEMS
Microbiol Lett 160:69–73
5. Oliver SP, Sordillo LM (1989) Approaches to the manipulation of mam‑
mary involution. J Dairy Sci 72:1647–1664
6. McDougall S, Arthur DG, Bryan MA, Vermunt JJ, Weir AM (2007) Clinical
and bacteriological response to treatment of clinical mastitis with one of
three intramammary antibiotics. N Z Vet J 55:161–170
7. Almeida RA, Luther DA, Park HM, Oliver SP (2006) Identification, isolation,
and partial characterization of a novel Streptococcus uberis adhesion
molecule (SUAM). Vet Microbiol 115:183–191
8. Rejman JJ, Turner JD, Oliver SP (1994) Characterization of lactoferrin
binding to the MAC-T bovine mammary epithelial cell line using a biotinavidon technique. Int J Biochem 26:201–206
9. Patel D, Almeida RA, Dunlap JR, Oliver SP (2009) Bovine lactoferrin serves
as a molecular bridge for internalization of Streptococcus uberis into
bovine mammary epithelial cells. Vet Microbiol 137:297–301
10. Chen X, Kerro-Dego O, Almeida RA, Fuller TE, Luther DA, Oliver SP (2011)
Deletion of sua gene reduces the ability of Streptococcus uberis to adhere
to and internalize into bovine mammary epithelial cells. Vet Microbiol
147:426–434
11. Prado ME, Almeida RA, Ozen C, Luther DA, Lewis MJ, Headrick SJ, Oliver
SP (2011) Vaccination of dairy cows with recombinant Streptococcus
uberis adhesion molecule induces antibodies that reduce adherence to
and internalization of S. uberis into bovine mammary epithelial cells. Vet
Immunol Immunopathol 141:201–208
12. Zadoks RN, Gillespie BM, Barkema HW, Sampion OC, Oliver SP, Schukken
YH (2003) Clinical, epidemiological and molecular characteristics of Streptococcus uberis infections in dairy herds. Epidemiol Infect 130:335–349
13. Jayarao BM, Gillespie BE, Lewis MJ, Dowlen HH, Oliver SP (1999) Epide‑
miology of Streptococcus uberis intramammary infections in a dairy herd.
Zentralbl Veterinarmed B 46:433–442
14. Ghaffar A, Haqqi T (2009) Immunization. In: Microbiology and Immunol‑
ogy On-Line Textbook: USC School of Medicine. http://www.microbiolo‑
gybook.org/ghaffar/immunization-ver2.htm. Accessed 10 July 2015
15. Foo DGW, Alonso S, Chow VTK, Poh CL (2007) Passive protection against
lethal enterovirus 71 infection in newborn mice by neutralizing antibod‑
ies elicited by a synthetic peptide. Microbes Infect 9:1299–1309
16. Hewetson JF, Little SF, Ivins BE, Johnson WM, Pittman PR, Brown JE, Norris
SL, Nielsen CJ (2008) An in vivo passive protection assay for the evalua‑
tion of immunity in AVA-vaccinated individuals. Vaccine 26:4262–4266
17. Ye J, Shao H, Hickman D, Angel M, Xu K, Cai Y, Song H, Fouchier RAM, Qin
A, Perez DR (2010) Intranasal delivery of an IgA monoclonal antibody
effective against sublethal H5N1 influenza virus infection in mice. Clin
Vaccine Immunol 17:1363–1370
18. Guidry J, Butler JE, Pearson PE, Weinland BT (1980) IgA, igG1, IgG2, IgM,
and BSA in serum and mammary secretion throughout lactation. Vet
Immunol Immunopathol 1:329–341

